Age—median (IQR) year |
68 (34–75) |
Male sex—No./total No. (%) |
5/7 (71.4) |
SCI level |
Cervical (number/sample (%)) |
5/7 (71.4) |
Thoracic T1-T6 (number/sample (%)) |
1/7 (14.3) |
Thoracic T7-T12 (number/sample (%)) |
1/7 (14.3) |
Lumbosacral (number/sample (%)) |
0/7 (0) |
SCI etiology |
Traumatic (number/sample (%)) |
4/7 (57.1) |
Vascular (number/sample (%)) |
2/7 (28.6) |
Iatrogenic (number/sample (%)) |
1/7 (14.3) |
AIS Impairment Scale |
A (number/sample (%)) |
4/7 (57.1) |
B (number/sample (%)) |
0/7 (0) |
C (number/sample (%)) |
2/7 (28.6) |
D (number/sample (%)) |
1/7 (14.3) |
E (number/sample (%)) |
0/7 (0) |
Tracheostomy (number/sample (%)) |
4/7 (57.1) |
Need to remove respiratory secretions (number/sample (%)) |
2/4 (50) |
Contact with Covid-19 patient (number/sample (%)) |
2/7 (28.6) |
Incubation period—media (IQR) dias |
6.5 (4–9) |
History of smoking (current or former) (number/sample (%)) |
3/7 (42.9) |
Coexisting disorders (number/sample (%)) |
Any |
0 (0) |
Hypertension |
4 (57.1) |
Diabetes |
1 (14.3) |
Dyslipidemia |
4 (57.1) |
Obesity |
3 (42.9) |
Cardiovascular disease |
3 (42.9) |
Pulmonary disease |
3 (42.9) |
Chronic renal disease |
0 (0) |
Cancer |
1 (14.3) |
Symptoms of Covid-19 onset (number/sample (%)) |
Fever |
6 (85.7) |
Dyspnea |
3 (42.9) |
Cough |
3 (42.9) |
Fatigue |
4 (57.1) |
Sputum production |
3 (42.9) |
Confusion |
2 (28.6) |
Gastrointestinal symptoms |
1 (14.3) |
Modified Early Warning System (MEWS) |
0–2 points(number/sample (%) |
2/7 (28.6) |
>3 points (number/sample (%) |
5/7 (71.4) |
CURB-65—if pneumonia |
0–1 points (number/sample (%) |
1/5 (20) |
>1 points (number/sample (%) |
4/5 (80) |